Further analysis using the Gene Expression Omnibus database showed that BD could reduce the expression of DAP3 in the luminal A subtype of breast cancer (MCF7 cells), indicating that DAP3 might be a possible target for BD intervention in breast cancer (91). This evidence concerns the gene DAP3 and Behcet disease.